Xenograft models for adrenocortical carcinoma-Reference-Cited by-同舟云学术

Xenograft models for adrenocortical carcinoma

Published:2016-02 Issue: Volume:421 Page:28-33
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Hantel Constanze,Beuschlein Felix

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference40 articles.

1. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients;Abiven;J. Clin. Endocrinol. Metab,2006

2. Clinical review: adrenocortical carcinoma: clinical update;Allolio;J. Clin. Endocrinol. Metab,2006

3. Integrated genomic characterization of adrenocortical carcinoma;Assie;Nat. Genet,2014

4. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma;Barlaskar;J. Clin. Endocrinol. Metab,2009

5. Corticotropin assay with transplantable adrenocortical tumor slices: application to the assay of adrenotropic pituitary tumors;Cohen;Cancer Res,1959

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human and Murine Cell Lines for Adrenocortical Carcinoma and Pheochromocytoma;Endocrines;2024-07-05

2. Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth;Cancers;2023-07-10

3. Preclinical Models of Adrenocortical Cancer;Cancers;2023-05-23

4. Targeting oncogenic Wnt/β-catenin signaling in adrenocortical carcinoma disrupts ECM expression and impairs tumor growth;2022-10-24

5. An update on adrenocortical cell lines of human origin;Endocrine;2022-06-28